EUVIMEDEUVIMED entdecken
Crossref

Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity

A Alper Öztürk, İrem Namlı, Abdurrahman Aygül

ASSAY and Drug Development Technologies · 01.04.2021 · 19 (3) · 156-175

DOI: 10.1089/adt.2020.1014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, erschienen am 01.04.2021. Verfasst von A Alper Öztürk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacterial InfectionsCOVID-19CefaclorCoinfectionDrug CompoundingEscherichia coliExcipientsIntestinal DiseasesKineticsMicrobial Sensitivity TestsNanoparticlesParticle SizePolylactic Acid-Polyglycolic Acid CopolymerPolymethacrylic AcidsStaphylococcus aureus

Stichwörter der Autor:innen

COVID-19Escherichia coliEudragit S100PLGAStaphylococcus aureuscefaclor monohydratecolon targetingnanoparticle

Substanzen

Anti-Bacterial AgentsExcipientsPolymethacrylic AcidsPolylactic Acid-Polyglycolic Acid Copolymermethylmethacrylate-methacrylic acid copolymerCefaclor

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
  • Department of Pharmaceutical Technology, Graduate School of Health Sciences, Anadolu University, Eskişehir, Turkey.
  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Çukurova University, Adana, Turkey.

Zitieren

APA

Alper Öztürk, A., Namlı, İ., & Aygül, A. (2021). Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity. ASSAY and Drug Development Technologies, 19(3), 156-175. https://doi.org/10.1089/adt.2020.1014

Vancouver

Alper Öztürk A, Namlı İ, Aygül A. Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity. ASSAY and Drug Development Technologies. 2021;19(3):156-175. doi:10.1089/adt.2020.1014

BibTeX
@article{Alperztrk2021,
  author = {Alper Öztürk, A and Namlı, İrem and Aygül, Abdurrahman},
  title = {Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity},
  journal = {ASSAY and Drug Development Technologies},
  year = {2021},
  volume = {19},
  number = {3},
  pages = {156--175},
  doi = {10.1089/adt.2020.1014}
}
Kostenlos starten →